18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mastocarcinoma therapy synergistically promoted by lysosome dependent apoptosis specifically evoked by 5-Fu@nanogel system with passive targeting and pH activatable dual function.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This manuscript describes a synergistic therapy for mastocarcinoma by pH and temperature dual-sensitive nanogel, and effects of microstructure, composition and properties of nanogel on the cellular response mechanism. The extracellular internalization of nanogels was obviously enhanced, due to the passive targeting function at T>VPTT. Interestingly, the increased cytotoxicity was further synergistically enhanced by an unexpected apoptosis as evoked by the 5-fluorouracil loaded nanogel (FLNG). The systemically evaluation of the effectors generated from different sub-cellular organelles including endosome, lysosome, autophagosome confirmed that it was a lysomal dependent apoptosis. Such specific apoptosis was mainly attributed to its activatable protonated PEI at low pH, which caused lysosomal membrane destruction and lysosomal enzyme cathepsin B (Cat B) leakage. This Cat B was then translocated to the mitochondria resulting in mitochondrial membrane permeability increase and mitochondrial membrane potential (MMP) decrease, followed by cytochrome c (Cyt C) release. Cyt C was the main molecule that evoked apoptosis as reflected by overexpression of caspase 9. Additionally, such lysosome dependent, apoptosis was further enhanced by the passive cellular targeting at T>VPTT. Thus, the tumor growth inhibition was synergistically enhanced by the extracellular temperature dependent passive targeting and intracellular pH activatable lysosomal dependent apoptosis.

          Related collections

          Author and article information

          Journal
          J Control Release
          Journal of controlled release : official journal of the Controlled Release Society
          Elsevier BV
          1873-4995
          0168-3659
          May 28 2017
          : 254
          Affiliations
          [1 ] International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China.
          [2 ] International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China; College of Pharmacy, Liaocheng University, 1Hunan Road, Liaocheng, Shandong 25000, China.
          [3 ] 3B's Research Group-Biomaterials, Biodegradables, and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Guimarães, Portugal; ICVS-3B's-PT Government Associate Laboratory, Braga, Guimarães, Portugal.
          [4 ] College of Pharmacy, Liaocheng University, 1Hunan Road, Liaocheng, Shandong 25000, China.
          [5 ] International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China; College of Pharmacy, Liaocheng University, 1Hunan Road, Liaocheng, Shandong 25000, China. Electronic address: liwei@smmu.edu.cn.
          Article
          S0168-3659(17)30145-1
          10.1016/j.jconrel.2017.03.038
          28342982
          b53f3d17-2900-438f-8813-b7ffc1f252d5
          History

          Apoptosis,Drug delivery,Mastocarcinoma therapy,Nanogel,Passive targeting

          Comments

          Comment on this article